Akero Therapeutics Inc (AKRO)
19.71
-1.09
(-5.24%)
USD |
NASDAQ |
May 10, 14:56
Akero Therapeutics Shares Outstanding: 68.95M for March 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 08, 2024 | 68.95M |
February 23, 2024 | 56.30M |
December 31, 2023 | 55.75M |
November 03, 2023 | 55.71M |
September 30, 2023 | 55.68M |
August 04, 2023 | 55.60M |
June 30, 2023 | 55.55M |
May 19, 2023 | 55.33M |
May 11, 2023 | 50.09M |
April 24, 2023 | 48.42M |
April 06, 2023 | 47.28M |
March 31, 2023 | 46.98M |
March 14, 2023 | 46.97M |
December 31, 2022 | 46.87M |
October 28, 2022 | 46.76M |
September 30, 2022 | 46.66M |
September 19, 2022 | 46.42M |
July 29, 2022 | 37.57M |
June 30, 2022 | 37.57M |
June 17, 2022 | 37.55M |
April 29, 2022 | 35.02M |
April 04, 2022 | 35.02M |
March 31, 2022 | 35.02M |
February 15, 2022 | 35.01M |
December 31, 2021 | 34.90M |
Date | Value |
---|---|
November 09, 2021 | 34.89M |
September 30, 2021 | 34.88M |
August 08, 2021 | 34.86M |
June 30, 2021 | 34.84M |
May 07, 2021 | 34.83M |
April 05, 2021 | 34.82M |
March 31, 2021 | 34.77M |
March 10, 2021 | 34.77M |
December 31, 2020 | 34.74M |
November 06, 2020 | 34.72M |
September 30, 2020 | 34.72M |
August 07, 2020 | 34.70M |
July 10, 2020 | 34.70M |
June 30, 2020 | 28.68M |
May 08, 2020 | 28.67M |
April 09, 2020 | 28.67M |
March 31, 2020 | 28.67M |
March 06, 2020 | 28.61M |
December 31, 2019 | 28.57M |
November 08, 2019 | 28.56M |
September 30, 2019 | 28.56M |
August 12, 2019 | 28.56M |
June 30, 2019 | 28.56M |
June 20, 2019 | 27.05M |
June 10, 2019 | 26.30M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
26.30M
Minimum
Jun 10 2019
68.95M
Maximum
Mar 08 2024
39.29M
Average
34.89M
Median
Shares Outstanding Benchmarks
Madrigal Pharmaceuticals Inc | 21.31M |
89bio Inc | 95.22M |
Viking Therapeutics Inc | 110.27M |
Eli Lilly and Co | 950.41M |
Ionis Pharmaceuticals Inc | 145.97M |